Valiant Laboratories Limited (VALIANTLAB.BO)
INR 127.0
(13.54%)
INR 127.0
(13.54%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 767.08 Million INR | 27.39% |
| 2022 | 602.17 Million INR | -1.49% |
| 2021 | 611.26 Million INR | 10020.2% |
| 2020 | 6.04 Million INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 Q4 | 767.08 Million INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 767.08 Million INR | 27.39% |
| 2023 Q2 | 608.7 Million INR | 0.0% |
| 2022 Q4 | 602.17 Million INR | 0.0% |
| 2022 FY | 602.17 Million INR | -1.49% |
| 2021 FY | 611.26 Million INR | 10020.2% |
| 2020 FY | 6.04 Million INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Ajanta Pharma Limited | 352.8 Million INR | -117.427% |
| Amrutanjan Health Care Limited | 17.28 Million INR | -4338.373% |
| Sigachi Industries Limited | 1.43 Billion INR | 46.377% |
| Bal Pharma Limited | 1.39 Billion INR | 45.07% |
| Ind-Swift Laboratories Limited | 166.21 Million INR | -361.498% |
| Medico Remedies Limited | 80.5 Million INR | -852.852% |
| Lasa Supergenerics Limited | 220.76 Million INR | -247.471% |
| Venus Remedies Limited | 413.3 Million INR | -85.6% |
| Sun Pharma Advanced Research Company Limited | 611.5 Million INR | -25.443% |
| Alpa Laboratories Limited | 52.46 Million INR | -1362.087% |
| Nectar Lifesciences Limited | 6.35 Billion INR | 87.93% |
| Shilpa Medicare Limited | 9.37 Billion INR | 91.817% |
| Aarti Drugs Limited | 5.64 Billion INR | 86.406% |
| Lupin Limited | 29.21 Billion INR | 97.375% |
| Aurobindo Pharma Limited | 66.47 Billion INR | 98.846% |
| Zydus Lifesciences Limited | 8.04 Billion INR | 90.462% |
| Windlas Biotech Limited | 36.41 Million INR | -2006.795% |
| Suven Life Sciences Limited | 7.09 Million INR | -10708.567% |
| Eris Lifesciences Limited | 27.81 Billion INR | 97.242% |
| J. B. Chemicals & Pharmaceuticals Limited | 3.77 Billion INR | 79.689% |
| Solara Active Pharma Sciences Limited | 10.11 Billion INR | 92.416% |
| Ipca Laboratories Limited | 14.38 Billion INR | 94.667% |
| Bliss GVS Pharma Limited | 998.4 Million INR | 23.169% |
| Achyut Healthcare Limited | - INR | -Infinity% |
| Sun Pharmaceutical Industries Limited | 32.73 Billion INR | 97.657% |
| Bajaj HealthCare Limited | 3.32 Billion INR | 76.952% |
| RPG Life Sciences Limited | - INR | -Infinity% |
| Mankind Pharma Limited | 2.07 Billion INR | 62.974% |
| Laurus Labs Limited | 25.77 Billion INR | 97.024% |
| Piramal Pharma Limited | 47.1 Billion INR | 98.371% |
| Syncom Formulations (India) Limited | 724.86 Million INR | -5.824% |
| Torrent Pharmaceuticals Limited | 40.22 Billion INR | 98.093% |
| Alembic Pharmaceuticals Limited | 5.13 Billion INR | 85.052% |
| Glenmark Pharmaceuticals Limited | 12.3 Billion INR | 93.768% |
| Unichem Laboratories Limited | 2.47 Billion INR | 69.008% |
| Sequent Scientific Limited | 4.87 Billion INR | 84.271% |
| Novartis India Limited | 69.7 Million INR | -1000.551% |
| Wanbury Limited | 1.16 Billion INR | 34.147% |
| Suven Pharmaceuticals Limited | 649.96 Million INR | -18.019% |
| Wockhardt Limited | 23.56 Billion INR | 96.744% |
| Themis Medicare Limited | 957.92 Million INR | 19.922% |
| Jagsonpal Pharmaceuticals Limited | 89.41 Million INR | -757.94% |
| Jubilant Pharmova Limited | 36.64 Billion INR | 97.906% |
| Glenmark Life Sciences Limited | 171.48 Million INR | -347.331% |
| Dr. Reddy's Laboratories Limited | 20.02 Billion INR | 96.168% |
| Divi's Laboratories Limited | 30 Million INR | -2456.947% |
| NATCO Pharma Limited | 3.71 Billion INR | 79.335% |
| Gufic Biosciences Limited | 3.32 Billion INR | 76.959% |
| IOL Chemicals and Pharmaceuticals Limited | 327.6 Million INR | -134.153% |
| Ind-Swift Limited | 10.13 Billion INR | 92.435% |
| Procter & Gamble Health Limited | 95.6 Million INR | -702.389% |
| FDC Limited | 205.18 Million INR | -273.85% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | 60.343% |
| Granules India Limited | 13.15 Billion INR | 94.167% |
| Medicamen Biotech Limited | 308.17 Million INR | -148.914% |
| Alkem Laboratories Limited | 14.18 Billion INR | 94.592% |
| AstraZeneca Pharma India Limited | 45.98 Million INR | -1568.227% |
| Biofil Chemicals and Pharmaceuticals Limited | 4.38 Million INR | -17377.421% |
| Brooks Laboratories Limited | 56.41 Million INR | -1259.62% |
| Megasoft Limited | 1.47 Billion INR | 47.834% |
| ZIM Laboratories Limited | 1.08 Billion INR | 29.512% |
| Strides Pharma Science Limited | 25.16 Billion INR | 96.952% |
| Neuland Laboratories Limited | 953.89 Million INR | 19.584% |
| Morepen Laboratories Limited | 289.99 Million INR | -164.519% |
| Hikal Limited | 8.17 Billion INR | 90.618% |
| Indoco Remedies Limited | 6.71 Billion INR | 88.584% |
| Aarti Pharmalabs Limited | 2.85 Billion INR | 73.108% |
| Kilitch Drugs (India) Limited | 316.46 Million INR | -142.391% |
| Mangalam Drugs & Organics Limited | 984.92 Million INR | 22.118% |
| Hester Biosciences Limited | 2.44 Billion INR | 68.611% |